In this study, metformin did not alter oxidative phosphorylation or glycolysis in normal non-cancer rectal tissue biopsies, importantly suggesting that the anti-metabolic effects of metformin may be tumour tissue-specific, which supports its potential utility as a radiosensitiser in rectal cancer
By doing this, it: Saves more nicotinamide so your body can make higher levels of NAD+ (often 2060% more in fat cells)
Metformin and Systemic Metabolism
Most patients begin noticing skin texture improvements toward the end of the first 30-day cycle
For anyone who relies on NSAIDs regularly whether for pain, inflammation, or another chronic condition this is an important consideration, and one where additional gut support can make a real difference
It's not about a winner or a loser